MICHIENZI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 9.897
EU - Europa 673
AS - Asia 355
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 8
OC - Oceania 2
Totale 10.943
Nazione #
US - Stati Uniti d'America 9.896
SG - Singapore 199
IT - Italia 157
UA - Ucraina 122
DE - Germania 107
CN - Cina 99
IE - Irlanda 92
SE - Svezia 91
KR - Corea 41
FI - Finlandia 38
FR - Francia 18
GB - Regno Unito 16
RU - Federazione Russa 15
EU - Europa 8
VN - Vietnam 7
BR - Brasile 5
JP - Giappone 5
PL - Polonia 4
CZ - Repubblica Ceca 3
ES - Italia 3
AU - Australia 2
BE - Belgio 2
CL - Cile 2
AL - Albania 1
CA - Canada 1
IR - Iran 1
MD - Moldavia 1
MN - Mongolia 1
NL - Olanda 1
PE - Perù 1
RO - Romania 1
SI - Slovenia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 10.943
Città #
Woodbridge 2.668
Wilmington 2.636
Houston 2.564
Fairfield 314
Ann Arbor 226
Chandler 217
Ashburn 179
Singapore 169
Seattle 143
Cambridge 104
Jacksonville 101
Rome 91
Dublin 89
Medford 69
Beijing 58
New York 52
Santa Clara 43
Dearborn 41
Lawrence 30
Creede 18
Mülheim 17
Boardman 15
Florence 14
San Mateo 14
Helsinki 12
Menlo Park 12
San Diego 9
Del Norte 8
Milan 7
Mountain View 7
Dong Ket 6
Norwalk 6
Phoenix 6
Verona 6
Chicago 5
Jinan 5
Moscow 5
Redwood City 5
São Paulo 5
Guangzhou 4
Hefei 4
London 4
Nanjing 4
Zhengzhou 4
Brno 3
Lappeenranta 3
Bari 2
Binasco 2
Brussels 2
Chengdu 2
Council Bluffs 2
Engelhard 2
Falls Church 2
Ferentino 2
Hebei 2
Kissimmee 2
Kraków 2
Madrid 2
Munich 2
Overland Park 2
Saint Petersburg 2
Salt Lake City 2
San Francisco 2
San Jose 2
Seoul 2
Supino 2
University Park 2
Warsaw 2
Wuhan 2
Antrodoco 1
Chisinau 1
Chiswick 1
Düsseldorf 1
Forcoli 1
Fremont 1
Gravina di Catania 1
Hounslow 1
Kilburn 1
Kunming 1
Lima 1
Logan 1
Los Angeles 1
Miami Beach 1
Nepi 1
Ningbo 1
Novo Mesto 1
Nürnberg 1
Palo Alto 1
Rotterdam 1
Shanghai 1
Shaoxing 1
St. George 1
Targu 1
Tianjin 1
Tokyo 1
Toronto 1
Washington 1
Yalova 1
Totale 10.077
Nome #
Resetting cancer stem cell regulatory nodes upon MYC inhibition. 448
ADAR1 restricts LINE-1 retrotransposition 444
Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection 435
The ADAR1 editing enzyme is encapsidated into HIV-1 virions 430
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 427
CPEB1 restrains proliferation of Glioblastoma cells through the regulation of p27(Kip1) mRNA translation 423
ADAR2 editing enzyme is a novel human immunodeficiency virus-1 proviral factor 418
Inhibition of human immunodeficiency virus type 1 replication by nuclear chimeric anti-HIV ribozymes in a human T lymphoblastoid cell line 415
Intracellular applications of ribozymes 411
The Rev protein is able to transport to the cytoplasm small nucleolar RNAs containing a Rev binding element 403
Two different snoRNAs are encoded in introns of amphibian and human L1 ribosomal protein genes 401
HIV-1 Infection Causes a Down-Regulation of Genes Involved in Ribosome Biogenesis 400
U1 small nuclear RNA chimeric ribozymes with substrate specificity for the Rev pre-mRNA of human immunodeficiency virus 397
Intracellular ribozyme applications 396
Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs 395
Ribozyme-mediated inhibition of HIV 1 suggests nucleolar trafficking of HIV-1 RNA 391
A novel small nucleolar RNA (U16) is encoded inside a ribosomal protein intron and originates by processing of the pre-mRNA 390
The HIV-1 Tat protein modulates CD4 expression in human T cells through the induction of miR-222. 384
Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases 381
A nucleolar localizing Rev binding element inhibits HIV replication 376
CC chemokine ligand 2 down-modulation by selected Toll-like receptor agonist combinations contributes to T helper 1 polarization in human dendritic cells 365
The lncRNA H19 positively affects the tumorigenic properties of glioblastoma cells and contributes to NKD1 repression through the recruitment of EZH2 on its promoter. 343
A nucleolar TAR decoy inhibitor of HIV-1 replication 336
RNA-mediated inhibition of HIV in a gene therapy setting 326
Use of adenoviral VAI small RNA as a carrier for cytoplasmic delivery of ribozymes 288
Restricting retrotransposons: ADAR1 is another guardian of the human genome 283
The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells. 242
Dual regulation of L-selectin (CD62L) by HIV-1: Enhanced expression by Vpr in contrast with cell-surface down-modulation by Nef and Vpu 192
Insights into the regulatory role of M6a epitranscriptome in glioblastoma 157
MEOX2 Regulates the Growth and Survival of Glioblastoma Stem Cells by Modulating Genes of the Glycolytic Pathway and Response to Hypoxia 67
The RNA editing enzyme ADAR2 restricts L1 mobility 58
Long Noncoding RNAs and Cancer Stem Cells: Dangerous Liaisons Managing Cancer 54
Glioblastoma stem cells express non-canonical proteins and exclusive mesenchymal-like or non-mesenchymal-like protein signatures 46
RNA editing in interferonopathies 46
Characterization of the molecular dysfunctions occurring in Aicardi-Goutières syndrome patients with mutations in ADAR1 37
Unraveling the complex role of MEOX2 in the pathogenesis and therapeutic resistance of glioblastoma stem-like cells 33
An essential role of adenosine deaminase acting on RNA 1 in coeliac disease mucosa 32
The RNA editing enzyme ADAR2 restricts L1 mobility 30
Totale 11.100
Categoria #
all - tutte 21.085
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.085


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.439 0 0 194 272 244 301 268 247 261 246 189 217
2020/20211.896 197 232 185 245 182 211 227 177 41 93 70 36
2021/2022386 10 22 38 27 7 45 11 15 26 50 39 96
2022/2023574 43 55 31 61 39 109 53 69 65 0 41 8
2023/2024275 32 4 14 1 15 57 11 1 46 9 17 68
2024/2025349 28 235 86 0 0 0 0 0 0 0 0 0
Totale 11.100